These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28179585)

  • 61. Radiation-induced epigenetic alterations after low and high LET irradiations.
    Aypar U; Morgan WF; Baulch JE
    Mutat Res; 2011 Feb; 707(1-2):24-33. PubMed ID: 21159317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Arsenic and human health effects: A review.
    Abdul KS; Jayasinghe SS; Chandana EP; Jayasumana C; De Silva PM
    Environ Toxicol Pharmacol; 2015 Nov; 40(3):828-46. PubMed ID: 26476885
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A genetic approach to cancer epigenetics.
    Feinberg AP
    Cold Spring Harb Symp Quant Biol; 2005; 70():335-41. PubMed ID: 16869770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
    Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
    Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genomic instability in multiple myeloma: mechanisms and therapeutic implications.
    Neri P; Bahlis NJ
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S69-82. PubMed ID: 23782016
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epigenetics and ocular diseases: from basic biology to clinical study.
    Yan B; Yao J; Tao ZF; Jiang Q
    J Cell Physiol; 2014 Jul; 229(7):825-33. PubMed ID: 24318407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M; Issa JP
    Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Arsenic as an environmental toxicant and a therapeutic agent: Foe and friend.
    Xu Y; Tokar EJ; Pi J
    Toxicol Appl Pharmacol; 2021 Mar; 415():115438. PubMed ID: 33548274
    [No Abstract]   [Full Text] [Related]  

  • 71. Epigenomic reprogramming in iAs-mediated carcinogenesis.
    George S; Cassidy RN; Saintilnord WN; Fondufe-Mittendorf Y
    Adv Pharmacol; 2023; 96():319-365. PubMed ID: 36858778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage
    Rao CV; Pal S; Mohammed A; Farooqui M; Doescher MP; Asch AS; Yamada HY
    Oncotarget; 2017 Aug; 8(34):57605-57621. PubMed ID: 28915699
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cause and consequences of genetic and epigenetic alterations in human cancer.
    Sadikovic B; Al-Romaih K; Squire JA; Zielenska M
    Curr Genomics; 2008 Sep; 9(6):394-408. PubMed ID: 19506729
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Environmental toxicants, epigenetics, and cancer.
    Pogribny IP; Rusyn I
    Adv Exp Med Biol; 2013; 754():215-32. PubMed ID: 22956504
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Conference report for the 2nd MC-GARD series on "Interplay among genetics, epigenetics and non-coding RNAs".
    Monk D
    Epigenetics; 2008; 3(4):230-3. PubMed ID: 18719402
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Arsenic co-carcinogenesis: Inhibition of DNA repair and interaction with zinc finger proteins.
    Zhou X; Speer RM; Volk L; Hudson LG; Liu KJ
    Semin Cancer Biol; 2021 Nov; 76():86-98. PubMed ID: 33984503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug-Related Carcinogenesis: Risk Factors and Approaches for Its Prevention.
    Belitskiy GA; Kirsanov KI; Lesovaya EA; Yakubovskaya MG
    Biochemistry (Mosc); 2020 Jan; 85(Suppl 1):S79-S107. PubMed ID: 32087055
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human GMDS gene fragment hypermethylation in chronic high level of arsenic exposure with and without arsenic induced cancer.
    Chanda S; Dasgupta UB; Mazumder DG; Saha J; Gupta B
    Springerplus; 2013; 2():557. PubMed ID: 24255851
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Key Characteristics Approach to Carcinogenic Hazard Identification.
    Guyton KZ; Rieswijk L; Wang A; Chiu WA; Smith MT
    Chem Res Toxicol; 2018 Dec; 31(12):1290-1292. PubMed ID: 30521319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and prevention.
    Li L; Chen F
    Curr Pharmacol Rep; 2016 Apr; 2(2):57-63. PubMed ID: 27134817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.